LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 69.06 | 17.25 | 3274 | 5242 | 0.6245 | 0.8890 | MN20160310_N02 | F12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 69.06 | 17.25 | 3870 | 5242 | 0.7382 | 0.9277 | MN20160310_N02 | F12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 71.03 | 17.25 | 3247 | 5367 | 0.6050 | 0.8822 | MN20160310_N02 | C11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 71.03 | 17.25 | 3297 | 5367 | 0.6143 | 0.8857 | MN20160310_N02 | C11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 71.03 | 17.25 | 3823 | 5367 | 0.7123 | 0.9197 | MN20160310_N02 | F12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 71.03 | 17.25 | 3993 | 5367 | 0.7440 | 0.9298 | MN20160310_N02 | F12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 73.00 | 17.25 | 3428 | 5546 | 0.6180 | 0.8877 | MN20160310_N02 | C11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 73.00 | 17.25 | 3473 | 5546 | 0.6261 | 0.8907 | MN20160310_N02 | C11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 73.00 | 17.25 | 4033 | 5546 | 0.7271 | 0.9249 | MN20160310_N02 | F12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 73.00 | 17.25 | 4134 | 5546 | 0.7453 | 0.9306 | MN20160310_N02 | F12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 74.97 | 17.25 | 3544 | 5618 | 0.6307 | 0.8926 | MN20160310_N02 | C11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 74.97 | 17.25 | 3600 | 5618 | 0.6407 | 0.8961 | MN20160310_N02 | C11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 74.97 | 17.25 | 4277 | 5618 | 0.7612 | 0.9357 | MN20160310_N02 | F12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 74.97 | 17.25 | 4361 | 5618 | 0.7761 | 0.9402 | MN20160310_N02 | F12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 76.94 | 17.25 | 3660 | 5681 | 0.6442 | 0.8976 | MN20160310_N02 | C11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 76.94 | 17.25 | 3711 | 5681 | 0.6532 | 0.9007 | MN20160310_N02 | C11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 76.94 | 17.25 | 4317 | 5681 | 0.7598 | 0.9354 | MN20160310_N02 | F12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 76.94 | 17.25 | 4379 | 5681 | 0.7707 | 0.9387 | MN20160310_N02 | F12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 78.91 | 17.25 | 3840 | 5730 | 0.6701 | 0.9067 | MN20160310_N02 | C11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 78.91 | 17.25 | 3878 | 5730 | 0.6767 | 0.9089 | MN20160310_N02 | C11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 78.91 | 17.25 | 4502 | 5730 | 0.7856 | 0.9432 | MN20160310_N02 | F12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 78.91 | 17.25 | 4551 | 5730 | 0.7942 | 0.9457 | MN20160310_N02 | F12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 80.88 | 17.25 | 3925 | 5826 | 0.6737 | 0.9081 | MN20160310_N02 | C11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 80.88 | 17.25 | 3968 | 5826 | 0.6811 | 0.9106 | MN20160310_N02 | C11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 80.88 | 17.25 | 4705 | 5826 | 0.8076 | 0.9498 | MN20160310_N02 | F12 |